Atlas Trials

Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

Clinical trial NCT01020214 · COMPLETED

Trial details

NCT number
NCT01020214
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2006-11-01
Primary completion
2006-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.